What is the brand name for ondansetron 4mg?
Ondansetron works by blocking one of the body’s natural substances (serotonin) that causes vomiting. Ondansetron is available under the following different brand names: Zofran, Zofran ODT, and Zuplenz.
What is ondansetron 4mg generic for?
What is the drug Zofran (ondansetron) used for? Zofran (ondansetron) is a medication used to prevent nausea and vomiting caused by cancer medications (chemotherapy), radiation therapy, and surgery.
What is the difference between ondansetron and ondansetron ODT?
Following oral administration ondansetron tablets and orally disintegrating tablets (ODT) are bioequivalent (essentially the same).
What is ondansetron ODT 4 mg tablet disintegrating?
Ondansetron orally disintegrating tablet is used to prevent nausea and vomiting caused by certain medical treatments. These treatments include: chemotherapy. radiation treatment.
What are the names for Zofran?
Description and Brand Names
- Zofran.
- Zofran ODT.
- Zuplenz.
Is ondansetron the same as Zofran?
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy and surgery.
Is Zofran ODT discontinued?
The Food and Drug Administration (FDA) has posted a discontinuation notice for Zofran Oral Solution (ondansetron; Novartis).
What’s the difference between Zofran and Zofran ODT?
Four- and 8-mg doses of either ZOFRAN Oral Solution or ZOFRAN ODT Orally Disintegrating Tablets are bioequivalent to corresponding doses of ZOFRAN Tablets and may be Reference ID: 3419008 4 Page 5 used interchangeably. One 24-mg ZOFRAN Tablet is bioequivalent to and interchangeable with three 8-mg ZOFRAN Tablets.
Are there any lawsuits against Zofran?
(Reuters) – GlaxoSmithKline PLC on Tuesday defeated lawsuits by 425 women alleging it failed to warn that taking the anti-nausea drug Zofran during pregnancy could cause birth defects, after a judge ruled their state-law claims were preempted by federal law.
Why is Zofran so hard to get?
WASHINGTON — The 32-mg dose of the anti-nausea drug ondansetron (Zofran) has been pulled from the market because of concerns about cardiac problems, the FDA announced Tuesday. Ondansetron is approved for preventing chemotherapy-induced nausea and vomiting, and, in lower doses, for postoperative nausea and vomiting.